Skip to content

People with HIV receiving methadone and HIV drugs spend less time with detectable viral load

Image from the webcast of Brittany Barker presenting at AIDS 2018.

Supervised drug consumption sites offer opportunities for HCV testing and treatment

Activists at the Towards Zero Together march in Amsterdam. Photo by Liz Highleyman.

Series of HIV outbreaks in people who inject drugs shows that ‘complacency is the new problem’

Series of HIV outbreaks in people who inject drugs shows that ‘complacency is the new problem’

HIV outbreak among people who inject drugs in Glasgow now involves over 100 infections, many homeless

Eight weeks of treatment with Epclusa cured almost all people with HCV receiving opioid substitution therapy

Alison Boyle presenting at The International Liver Congress, 2018. Image credit: @katjc1

Treatment with extended-release naltrexone increases chances that HIV-positive prisoners will maintain viral suppression after release

Sandra Springer at CROI 2018. Photo by Liz Highleyman.

Transgender women in Los Angeles are more likely to be in high HIV incidence clusters than any other group

Manon Ragonnet-Cronin at CROI 2018. Photo by Liz Highleyman.

Harm reduction scale-up needed to eliminate HCV in people who inject drugs, European model predicts

Hepatitis C testing linked to reduced opioid use among people who inject drugs

Hooman Farhang Zangneh presenting at The Liver Meeting 2017. Photo by Liz Highleyman, hivandhepatitis.com